Stefan Scheuerer

684 total citations
14 papers, 552 citations indexed

About

Stefan Scheuerer is a scholar working on Pharmacology, Pharmacology and Molecular Biology. According to data from OpenAlex, Stefan Scheuerer has authored 14 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 6 papers in Pharmacology and 4 papers in Molecular Biology. Recurrent topics in Stefan Scheuerer's work include Inflammatory mediators and NSAID effects (5 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Drug Transport and Resistance Mechanisms (3 papers). Stefan Scheuerer is often cited by papers focused on Inflammatory mediators and NSAID effects (5 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Drug Transport and Resistance Mechanisms (3 papers). Stefan Scheuerer collaborates with scholars based in Germany, Australia and United Kingdom. Stefan Scheuerer's co-authors include Gerd Geißlinger, Flora Beiche, Kay Brune, Margarete Goppelt‐Struebe, Dominique Turck, Yunhai Cui, Peter Sieger, Thomas Fox, Paul Czodrowski and Jan M. Kriegl and has published in prestigious journals such as FEBS Letters, Journal of Pharmacology and Experimental Therapeutics and Psychopharmacology.

In The Last Decade

Stefan Scheuerer

14 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stefan Scheuerer Germany	9	253	163	121	108	76	14	552
David J. Spalding United Kingdom	13	138 0.5×	72 0.4×	154 1.3×	81 0.8×	169 2.2×	21	579
Shawn D. Doran United States	16	87 0.3×	99 0.6×	272 2.2×	153 1.4×	54 0.7×	20	747
Géraldine Pénarier France	11	447 1.8×	138 0.8×	167 1.4×	110 1.0×	32 0.4×	13	769
Bo‐Hua Zhong China	13	99 0.4×	129 0.8×	207 1.7×	108 1.0×	74 1.0×	59	587
Irena Loryan Sweden	15	69 0.3×	46 0.3×	130 1.1×	115 1.1×	103 1.4×	33	624
C. DUFRESNE United States	8	248 1.0×	37 0.2×	284 2.3×	91 0.8×	56 0.7×	14	616
Cory M. Stiff United States	13	676 2.7×	170 1.0×	333 2.8×	245 2.3×	40 0.5×	17	1.1k
Loqman A. Mohamed United States	10	71 0.3×	175 1.1×	119 1.0×	44 0.4×	21 0.3×	13	454
Ebru Bodur Türkiye	15	131 0.5×	54 0.3×	172 1.4×	52 0.5×	12 0.2×	38	589
Xingrong Liu United States	10	77 0.3×	38 0.2×	188 1.6×	112 1.0×	152 2.0×	21	726

Countries citing papers authored by Stefan Scheuerer

Since Specialization

Citations

This map shows the geographic impact of Stefan Scheuerer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Scheuerer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Scheuerer more than expected).

Fields of papers citing papers by Stefan Scheuerer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Scheuerer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Scheuerer. The network helps show where Stefan Scheuerer may publish in the future.

Co-authorship network of co-authors of Stefan Scheuerer

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Scheuerer. A scholar is included among the top collaborators of Stefan Scheuerer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Scheuerer. Stefan Scheuerer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Stopfer, Peter, Ralf Lotz, Stefan Scheuerer, et al.. (2024). Beyond CL and VSS: A comprehensive approach to human pharmacokinetic predictions. Drug Discovery Today. 29(12). 104238–104238. 2 indexed citations

Wallman, Mikael, et al.. (2021). An Integrative Approach for Improved Assessment of Cardiovascular Safety Data. Journal of Pharmacology and Experimental Therapeutics. 377(2). 218–231. 3 indexed citations

Becker, Robert E., Natalia Gass, Lothar Kußmaul, et al.. (2019). NMDA receptor antagonists traxoprodil and lanicemine improve hippocampal-prefrontal coupling and reward-related networks in rats. Psychopharmacology. 236(12). 3451–3463. 8 indexed citations

Borghardt, Jens Markus, et al.. (2017). Modeling energy intake and body weight effects of a long-acting amylin analogue. Journal of Pharmacokinetics and Pharmacodynamics. 45(2). 215–233. 6 indexed citations

Sieger, Peter, Yunhai Cui, & Stefan Scheuerer. (2017). pH-dependent solubility and permeability profiles: A useful tool for prediction of oral bioavailability. European Journal of Pharmaceutical Sciences. 105. 82–90. 41 indexed citations

Mack, Jürgen, et al.. (2011). Discovery of BI 99179, a potent and selective inhibitor of type I fatty acid synthase with central exposure. Bioorganic & Medicinal Chemistry Letters. 21(19). 5924–5927. 20 indexed citations

Tye, Heather, J. Prestle, Stefan Scheuerer, et al.. (2010). Novel 6,7,8,9-tetrahydro-5H-1,4,7,10a-tetraaza-cyclohepta[f]indene analogues as potent and selective 5-HT2C agonists for the treatment of metabolic disorders. Bioorganic & Medicinal Chemistry Letters. 21(1). 34–37. 21 indexed citations

Czodrowski, Paul, Jan M. Kriegl, Stefan Scheuerer, & Thomas Fox. (2009). Computational approaches to predict drug metabolism. Expert Opinion on Drug Metabolism & Toxicology. 5(1). 15–27. 41 indexed citations

Ring, Arne, et al.. (2005). Ibuprofen Extrudate, a Novel, Rapidly Dissolving Ibuprofen Formulation: Relative Bioavailability Compared to Ibuprofen Lysinate and Regular Ibuprofen, and Food Effect on All Formulations. The Journal of Clinical Pharmacology. 45(9). 1055–1061. 46 indexed citations

10.

Euller-Ziegler, L, Patrick Vélicitat, Erich Bluhmki, et al.. (2001). Meloxicam: a review of its pharmacokinetics, efficacy and tolerability following intramuscular administration. Inflammation Research. 50(S1). 5–9. 31 indexed citations

11.

Hanft, Gertraud, Dominique Turck, Stefan Scheuerer, & Ralf Sigmund. (2001). Meloxicam oral suspension: a treatment alternative to solid meloxicam formulations. Inflammation Research. 50(S1). 35–37. 34 indexed citations

12.

Scheuerer, Stefan, Stephen D. Hall, Kenneth M. Williams, & Gerd Geißlinger. (1998). Effect of clofibrate on the chiral inversion of ibuprofen in healthy volunteers*. Clinical Pharmacology & Therapeutics. 64(2). 168–176. 12 indexed citations

13.

Scheuerer, Stefan, K. Williams, Roland Brugger, et al.. (1998). Effect of Clofibrate on the Chiral Disposition of Ibuprofen in Rats. Journal of Pharmacology and Experimental Therapeutics. 284(3). 1132–1138. 5 indexed citations

14.

Beiche, Flora, Stefan Scheuerer, Kay Brune, Gerd Geißlinger, & Margarete Goppelt‐Struebe. (1996). Up‐regulation of cyclooxygenase‐2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Letters. 390(2). 165–169. 282 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact